Genmab A (GMAB) Times Interest Earned (2019 - 2026)
Genmab A (GMAB) posted Times Interest Earned of -$1.2 for Q1 2026, up 79.74% on a QoQ basis from -$5.92 in Q3 2025, and up 71.28% year-over-year from -$0.7 in Q1 2025.
Genmab A (GMAB) Times Interest Earned (2019 - 2026) Analysis & Trends
Genmab A's Times Interest Earned history runs 5 years deep, the most recent figure standing at -$1.2 for Q1 2026.
- Quarterly Times Interest Earned rose 71.28% year-over-year to -$1.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.24 (up 47.03% YoY) and the FY2025 annual result came in at $3.96, up 18.53% from the prior year.
- Times Interest Earned was -$1.2 for Q1 2026 at Genmab A, up from -$5.92 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$1.2 in Q1 2026 and bottomed at -$146.33 in Q4 2024.
- A 3-year average of -$21.64 and a median of -$4.13 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2025 — Times Interest Earned slumped 61.96% — and 2026, when it surged 71.28%.
- Genmab A's Times Interest Earned stood at -$146.33 in 2024, then surged by 95.95% to -$5.92 in 2025, then soared by 79.74% to -$1.2 in 2026.
- Business Quant data shows GMAB's Times Interest Earned at -$1.2 in Q1 2026, -$5.92 in Q3 2025, and -$4.09 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | -1.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 |
| Sep 30, 2025 | -5.92 |
| Jun 30, 2025 | -4.09 |
| Mar 31, 2025 | -4.18 |
| Dec 31, 2024 | -146.33 |
| Sep 30, 2024 | -3.66 |
| Jun 30, 2024 | -4.40 |
| Mar 31, 2024 | -3.31 |
| Sep 30, 2020 | -2,383.21 Bn |
| Dec 31, 2019 | -215.22 |